Management of antimalarial-refractory cutaneous lupus erythematosus

Lupus

Volumn 6, Issue 2, 1997, Pages 203-208

  Callen, J P ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Cutaneous lupus erythematosus; Discoid LE; Subacute cutaneous LE; Therapy of lupus erythematosus

Indexed keywords

ANTIMALARIAL AGENT; CARBAMAZEPINE; CYTOKINE; DILTIAZEM; GOLD; GRISEOFULVIN; IMMUNOSUPPRESSIVE AGENT; LEPROSTATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PHENYTOIN; RETINOID; SULFONYLUREA DERIVATIVE; THIAZIDE DIURETIC AGENT;

ARTICLE; PRIORITY JOURNAL; SKIN LUPUS ERYTHEMATOSUS;

EID: 0031040519     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339700600216     Document Type: Article

References (37)

1. Black AA, McCauliffe DP, Sontheimer RD. Prevalence of acne rosacea in a Rheumatic-Skin disease subspecialty clinic. Lupus 1992; 1: 229-237.
2. Almeida L, Grossman M. Widespread dermatophyte infections that mimic collagen-vascular disease. J Am Acad Dermatol 1990; 23: 955-857.
3. Feldmann R, Salomon D, Saurat J-H. The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus. Dermatology 1994; 189: 425-427.
4. Lipsker D et al. Chloroquine-quinacrine association in resistant cutaneous lupus. Dermatology 1995; 190: 257-258.
5. Callen JP, Spencer LV, Burruss JB, Holtman J. Azathioprine: An effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis. Arch Dermatol 1991; 127: 515-522.
6. Tsokos GC, Caughman SW, Klippel JH. Successful treatment of generalized discoid skin lesions with azathioprine. Its use in a patient with systemic lupus erythematosus. Prog Dermatol 1974; 8: 5-9.
7. Ashinoff R, Werth VP, Frank AG Jr. Resistant discoid lupus erythematosus of palms and soles: Successful treatment with azathioprine J Am Acad Dermatol 1988; 19: 961-965.
8. Goldstein E, Carey W. Discoid lupus erythematosus: Successful treatment with oral methotrexate. Arch Dermatol 1994; 130: 938-939.
9. Bottomley WW, Goodfield M. Methotrexate for the treatment of severe mucocutaneous lupus erythematosus. Br J Dermatol 1995; 133: 311-314.
10. Schulz EJ, Menter MA. Treatment of discoid and subacute cutaneous lupus erythematosus with cyclophosphamide. Br J Dermatol 1971; 85: 60-65.
11. Yung RL, Richardson BC. Cytarabine therapy for refractory cutaneous lupus. Arthritis Rheum 1995; 38: 1341-1343.
12. Heule F, vanJoost T, Beukers R. Cyclosporine in the treatment of lupus erythematosus. Arch Dermatol 1986; 122: 973-974.
13. Yell JA, Burge SM. Cyclosporin and discoid lupus erythematosus. Br J Dermatol 1994; 131: 132-133.
14. Lernia VD, Bisighini G. Discoid lupus erythematosus during treatment with cyclosporine. Acta Derm Venereol 1996; 76: 87-88.
15. Piette J-C et al. High-dose immunoglobulins in the treatment of refractory cutaneous lupus erythematosus. Open trial in 5 cases. Arthritis Rheum 1995; 38: S304 (abstract).
16. Coburn PR, Shuster S. Dapsone and discoid lupus erythematosus. Br J Dermatol 1982; 106: 105-106.
17. Lindskov R, Reymann F. Dapsone in the treatment of cutaneous lupus erythematosus. Dermatologica 1986; 172: 214-217.
18. Ruzicka T, Goerz G. Dapsone in the treatment of lupus erythematosus. Br J Dermatol 1981; 104: 53-56.
19. Jakes JT, Dubois EL, Quismorio FT Jr. Antileprosy drugs in the treatment of systemic (SLE) and discoid lupus erythematosus (discoid LE). Arthr Rheum 1982; 25: 580.
20. Hall RP et al. Bullous eruption of systemic lupus erythematosus: Dramatic response to dapsone therapy. Ann Intern Med 1982; 97: 165-170.
21. Holtman J, Neustadt D, Callen JP. Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. J Rheumatol 1990; 17: 122-1225.
22. Krivanek JFC et al. Clofazimine (Lamprene) in the treatment of discoid lupus erythematosus. Australasian J Dermatol 1976; 17: 108-110.
23. Krivanek JFC, Paver WKA. Further study of the use of clofazimine in discoid lupus erythematosus. Australasian J Dermatol 1980; 21: 169-171.
24. Grosshans E, Illy G. Thalidomide therapy for inflammatory dermatoses. Int J Dermatol 1984; 23: 598-602.
25. Atra E, Sato EI. Treatment of the cutaneous lesions of systemic lupus erythematosus with thalidomide. Clin Exp Rheumatol 1993; 11: 487-493.
26. Ayres S Jr, Mihan R. Lupus erythematosus and Vitamin E: an effective and non-toxic therapy. Cutis 1974; 23: 49-54.
27. Yell JA, Burge S, Wojnarowska F. Vitamin E and discoid lupus erythematosus. Lupus 1992; 1: 303-305.
28. Dalziel K et al. Treatment of chronic discoid lupus erythematosus with an oral gold compound (auranofin). Br J Dermatol 1986; 115: 211-216.
29. Steinkjer B. Auranofin in the treatment of discoid lupus erythematosus. J Dermatol Treat 1991; 2: 27-29.
30. Rodriquez-Castellanos MA, Rubio JB, Gomez JFB, Mendoza AG. Phenytoin in the treatment of discoid lupus erythematosus. Arch Dermatol 1995; 131: 620-621.
31. Nicolas J-F, Thivolet J, Kanitkis J, Lyonnet S. Response of discoid and subacute cutaneous lupus erythematosus to recombinant interferon alpha 2a. J Invest Dermatol 1990; 95: 142S-145S.
32. Tebbe B, Lauy M, Gollnick H. Therapy of cutaneous lupus erythematosus with recombinant interferon alpha-2a: a case report. Eur J Dermatol 1992; 2: 2153-255.
33. Prinz JC et al. Treatment of severe cutaneous lupus erythematosus with a chimeric CD4 monoclonal antibody, CM-T412. J Am Acad Dermatol 1996; 34: 244-252.
34. Newton RC et al. Mechanism-oriented assessment of isotretinoin in chronic or subacute lupus erythematosus. Arch Dermatol 1986; 122: 180-176.
35. Furner BB. Subacute cutaneous lupus erythematosus response to isotretinoin. Int J Dermatol 1990; 29: 587-590.
36. Ruzicka T, Meurer M, Brown-Falco O. Treatment of cutaneous lupus erythematosus with etretinate. Acta Derm Venereol (Stockh) 1985, 65: 324-329.
37. Green LS et al. Clinical and immunologic features of livedo reticularis in lupus erythematosus: Successful therapy with etretinate. J Dermatol Treat 1989; 1: 19-22.